{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:12:48Z","timestamp":1779120768172,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.eplepsyres.2016.08.027","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T09:29:37Z","timestamp":1472462977000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients"],"prefix":"10.1016","volume":"127","author":[{"given":"Yoshiaki","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohito","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1528-1157.2003.44802.x","article-title":"Lipoprotein(a) concentration increases during treatment with carbamazepine","volume":"44","author":"Bramswig","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Schmidt, D., Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1528-1157.1992.tb02299.x","article-title":"The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients","volume":"33","author":"Calandre","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00002826-199404000-00010","article-title":"Effect of chronic antiepileptic treatment on biochemical parameters","volume":"17","author":"Erminio","year":"1994","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eplepsyres.2007.03.010","article-title":"Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy","volume":"74","author":"Hamed","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0035","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0006-2952(85)90670-7","article-title":"Enhancement of peroxisomal beta-oxidation in the liver of rats and mice treated with valproic acid","volume":"34","author":"Horie","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0040","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archneur.1993.00540060030012","article-title":"Serum lipid levels during carbamazepine medication. A prospective study","volume":"50","author":"Isoj\u00e4rvi","year":"1993","journal-title":"Arch. Neurol."},{"issue":"Pt A","key":"10.1016\/j.eplepsyres.2016.08.027_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejphar.2015.03.089","article-title":"Innovative pharmaceutical interventions in cardiovascular disease: focusing on the contribution of non-HDL-C\/LDL-C-lowering versus HDL-C-raising: a systematic review and meta-analysis of relevant preclinical studies and clinical trials","volume":"763","author":"K\u00fchnast","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1194\/jlr.R032326","article-title":"Sterols in spermatogenesis and sperm maturation","volume":"54","author":"Keber","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0055","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5551\/jat.7237","article-title":"Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS)","volume":"18","author":"Kitamura","year":"2011","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1528-1157.1992.tb02302.x","article-title":"Associations between risk factors for valproate hepatotoxicity and altered valproate metabolism","volume":"33","author":"Kondo","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2008.11.008","article-title":"Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells","volume":"234","author":"Lambert","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0070","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths","volume":"370","author":"Prospective Studies Collaboration","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","article-title":"Antiepileptic drugs and markers of vascular risk","volume":"12","author":"Lopinto-Khoury","year":"2010","journal-title":"Curr. Treat Options Neurol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00415-002-0731-3","article-title":"Polycystic ovaries, obesity and insulin resistance in women with epilepsy: a comparative study of carbamazepine and valproic acid in 105 women","volume":"249","author":"Luef","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eplepsyres.2009.04.004","article-title":"Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment","volume":"86","author":"Luef","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0090","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eplepsyres.2011.10.001","article-title":"Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein","volume":"98","author":"Mintzer","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0100","first-page":"MT50","article-title":"The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy","volume":"10","author":"Nikolaos","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0105","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/pds.2186","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction stroke, and death in patients with or without previous stroke: a nationwide cohort study","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0110","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1468-1331.2012.03708.x","article-title":"Characterization of glucose homeostasis and lipid profile in adult seizure-free, epileptic patients in Asian population","volume":"19","author":"Phabphal","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/01.WNL.0000048209.07526.86","article-title":"Fasting serum insulin and lipid levels in men with epilepsy","volume":"60","author":"Pylv\u00e4nen","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.yebeh.2006.02.008","article-title":"Insulin-related metabolic changes during treatment with valproate in patients with epilepsy","volume":"8","author":"Pylv\u00e4nen","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1528-1157.1999.tb00744.x","article-title":"Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study","volume":"40","author":"Sudhop","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2010.01372.x","article-title":"Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine","volume":"190","author":"Svalheim","year":"2010","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0135","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1253\/circj.CJ-09-0861","article-title":"Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events \u2212the JALS-ECC \u2212","volume":"74","author":"Tanabe","year":"2010","journal-title":"Circ. J."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1476-5381.2012.02140.x","article-title":"Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1\/2 pathway","volume":"168","author":"Turpin","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.eplepsyres.2015.03.002","article-title":"Antiepileptic drug use for treatment of epilepsy and dyslipidemia: systematic review","volume":"113","author":"Vyas","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1248\/bpb.35.487","article-title":"Influence of concomitant antiepileptic drugs on plasma lamotrigine concentration in adult Japanese epilepsy patients","volume":"35","author":"Yamamoto","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0155","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00228-014-1719-5","article-title":"Impact of cytochrome P450 inducers with or without inhibitors on the serum clobazam level in patients with antiepileptic polypharmacy","volume":"70","author":"Yamamoto","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2016.08.027_bib0160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/BF00208485","article-title":"Changes of serum lipid patterns during long-term anticonvulsive treatment","volume":"71","author":"Zeitlhofer","year":"1993","journal-title":"Clin. Investig."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116301486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116301486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:36:14Z","timestamp":1760276174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121116301486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":32,"alternative-id":["S0920121116301486"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.08.027","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}